Please use this identifier to cite or link to this item:
Title: L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis.
Authors: Ralph AP
Kelly PM
Anstey NM
Citation: Trends in microbiology 2008-07; 16(7): 336-44
Abstract: Worsening drug resistance and the need for prolonged treatment in tuberculosis (TB) require innovative solutions including investigation of inexpensive, safe adjunctive immunotherapies. L-arginine, the precursor of nitric oxide, and vitamin D recently have elucidated mycobactericidal and immunomodulatory actions against TB and are deficient in people with TB. We review the potential of these agents as adjunctive TB immunotherapies and explore how comparative clinical trials might help clarify their relative importance in the human TB immune response. By enhancing mycobacterial killing in macrophages, L-arginine and vitamin D might have the potential to enable shorter duration of treatment, reduced infectivity and improved response in drug-resistant TB.
Click to open PubMed article:
Journal title: Trends in microbiology
Publication Date: 2008-07
ISSN: 0966-842X
Type: Journal Article
DOI: 10.1016/j.tim.2008.04.003
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing